Table 2.
Adjusted odds ratios for 30-day mortality and severe shock at index diagnosis
| Characteristic | 30-day mortality | Severe shock | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | |
| Age (years) | 1.00 | 0.98–1.02 | 0.637 | 0.99 | 0.98–1.01 | 0.465 |
| Charlson comorbidity index | 1.09 | 0.98–1.22 | 0.110 | 1.08 | 0.99–1.18 | 0.083 |
| Physical stressor as trigger of Takotsubo Cardiomyopathy | 3.93 | 1.71–9.05 | < 0.001 | 4.25 | 2.50–7.21 | < 0.001 |
| Troponin I, peak (ng/mL) | 1.00 | 0.99–1.01 | 0.891 | 1.00 | 0.99–1.01 | 0.982 |
| Left ventricle ejection fraction (%) | 0.95 | 0.93–0.98 | < 0.001 | 0.95 | 0.94–0.97 | < 0.001 |
| Atypical wall motion abnormality | 0.56 | 0.21–1.50 | 0.251 | 0.66 | 0.34–1.25 | 0.199 |
| Age (years) | 1.00 | 0.99–1.02 | 0.565 | 0.99 | 0.98–1.01 | 0.342 |
| High comorbidity | 1.57 | 0.91–2.72 | 0.104 | 1.25 | 0.86–1.48 | 0.150 |
| Physical stressor as trigger of Takotsubo Cardiomyopathy | 4.04 | 1.76–9.28 | < 0.001 | 4.21 | 2.49–7.13 | < 0.001 |
| Troponin I, peak (ng/mL) | 1.00 | 0.99–1.01 | 0.872 | 1.00 | 0.99–1.01 | 0.992 |
| Left ventricle ejection fraction (%) | 0.95 | 0.93–0.98 | < 0.001 | 0.95 | 0.93–0.97 | < 0.001 |
| Atypical wall motion abnormality | 0.52 | 0.19–1.40 | 0.196 | 0.66 | 0.35–1.26 | 0.208 |
CI: confidence interval, HR: hazard ratio, OR: odds ratio